Discover: Interactive CHRO Panel: How Roche, Novartis & Merck Group Are Redesigning the Life Sciences Enterprise at Scale for an AI‑Enabled Future
8:40 am - Tuesday 29th September 2026
- How leaders are redesigning enterprise operating models, rethinking what work is done by humans vs systems vs AI agents – and what this means for structure, accountability, and decision‑making at scale
- The real choices organisations are making around build vs buy vs plug‑and‑play across the enterprise – and why similar companies are landing on very different technology, capability, and delivery models
- Why ‘do more with less, faster’ is an outcome, not a strategy – unpacking the true drivers of enterprise reinvention – including speed, experience, resilience, and long‑term capability building